Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The push, the pull and the periphery.

C M Oakley1

  • 1Department of Medicine (Clinical Cardiology), Hammersmith Hospital, London, UK.

Australian and New Zealand Journal of Medicine
|October 1, 1992
PubMed
Summary

Improving heart function requires effective treatments. Angiotensin converting enzyme inhibitors (ACEI) reduce mortality and improve survival in heart failure patients, though challenges with exercise tolerance and fatigue persist.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy.

British medical journal·2010
Same author

Surgical treatment of secundum atrial septal defect in the older patient.

Italian heart journal : official journal of the Italian Federation of Cardiology·2001
Same author

Endocarditis: problems--patients being treated for endocarditis and not doing well.

Heart (British Cardiac Society)·2001
Same author

Spontaneous early clinical remission of myocarditis without immunosuppressive treatment.

Italian heart journal : official journal of the Italian Federation of Cardiology·2000
Same author

Myocarditis, pericarditis and other pericardial diseases.

Heart (British Cardiac Society)·2000
Same author

Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review.

JAMA·2000

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Current heart failure treatments have limitations.
  • Inotropes are only for short-term use, and digitalis has feeble effects.
  • Phosphodiesterase inhibitors may increase sudden death mortality.

Purpose of the Study:

  • To evaluate the role of angiotensin converting enzyme inhibitors (ACEI) in heart failure treatment.
  • To assess the impact of ACEI on mortality, ventricular ectopy, and sudden death.
  • To explore the limitations of existing heart failure therapies.

Main Methods:

  • Review of clinical trial data, including CONSENSUS, V-HeFT-2, and SOLVD.
  • Analysis of the effects of diuretics, nitrates, and ACEI on heart function and patient outcomes.

Main Results:

  • ACEI are the cornerstone of heart failure treatment, reducing mortality and improving survival.
  • ACEI may reduce ventricular ectopy by improving left ventricular function.
  • Despite reducing overall mortality, ACEI did not diminish sudden death incidence in the SOLVD trial.

Conclusions:

  • ACEI significantly improve outcomes in heart failure patients.
  • Further research is needed to address persistent symptoms like fatigue and improve exercise tolerance.
  • The search for effective chronic oral inotropes remains a critical unmet need in heart failure management.

Related Experiment Videos